PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.
about
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infectionRole of PD-1 in HIV pathogenesis and as target for therapyHomeostasis and function of regulatory T cells in HIV/SIV infectionCostimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis CPD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma ViremiaHIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activationChloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNAImmune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic optionsExpression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects.Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosisHIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.Viral infection of human lung macrophages increases PDL1 expression via IFNβ.New insights into type I interferon and the immunopathogenesis of persistent viral infections.Monocyte and interferon based therapy for the treatment of ovarian cancer.Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection.Modulation of innate host factors by Mycobacterium avium complex in human macrophages includes interleukin 17.HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.Plasmacytoid dendritic cells in HIV infection.HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung FibroblastsPD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.Modulation of HIV-1-induced activation of plasmacytoid dendritic cells by 6-desfluoroquinolones.Immunity and immunopathology to viruses: what decides the outcome?Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity.Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study[Plasmacytoid dendritic cells: the novel Eldorado for antiviral therapy?].Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes.Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.
P2860
Q24564396-501034D3-55A0-47EE-ADF6-E521D5D3439EQ24634293-3F2BA6E7-8466-4DE1-868B-B63806385210Q26995345-DB1E5247-5AFE-40B2-92A9-FF0A9E3D71A4Q27490355-67F27181-272F-4814-A6CB-8696827D214EQ28551329-DD0776D6-EE26-4A87-8CC8-4EDDD63D0C2BQ33359564-2A27F072-9C35-4CB2-9F68-204EE3264167Q33613674-D46EFAC8-DCAE-4995-B6F0-4724485F159BQ33893665-0D2267D8-6920-4F36-BC6B-2D5E8FB33110Q33992829-805319A7-F7C4-4187-9F26-1CBD0CFEB39DQ34466498-DBBA424F-E9CA-4848-9459-14FE06F7C08BQ34683647-4604C96C-81F9-4EFB-9A88-C08A83A86D33Q34992712-6A449472-BA41-4E19-B36C-ADC132A00B21Q35120242-DC85B705-C27E-4F06-92AF-FB54CA06EE77Q35230813-AAC58DCC-D327-428E-BEF0-C043DC66B3B1Q35399263-53B7F3D5-4BD3-4079-8EA8-ED04EEDEF46FQ35553567-281FD9AC-AD6B-43A8-A1D8-AAC7B832B7DCQ35578386-DCBDDE09-D822-4FAE-A4D2-4B73F8E29362Q35648751-B698E02E-3B86-4A33-AD05-DE92FD6BC0D8Q35973378-1F32FF80-3A86-42CF-817C-F1F3FF3577CAQ36039709-92C6946E-1B78-499A-9DFF-E60A479904EDQ36109361-7AD1BBE2-38BD-48C3-BEFF-B989E723C538Q36253035-9BA0E65F-4F50-44CD-AB92-2A5A5A1ABE69Q36770954-86C79790-15B7-4D18-A784-B89B6AB19FDAQ37019332-FFC308F3-3EB8-461D-A4C2-9B629EB73260Q37229398-4C5AFAC9-00C5-402F-A507-18E69EC589FDQ37415466-2A53A0B8-83E8-4636-B775-FF01670AA88FQ37469795-049512A4-7BCE-4B8A-BD8C-F6CA54C79A09Q37686175-46EA05F9-E4DF-4FB2-BB93-2854488C6B09Q37767587-B62A0FC9-C155-48D0-B26B-17F6A278D075Q38181142-7BC37DDF-6230-44D2-B219-7A7A04C76056Q38826536-00024B17-BC3F-443A-B0CA-3CDB9E7A95DAQ39827583-3A4FA4C6-4070-46FA-A106-5A504D70E5D0Q40846562-EAE2949B-2561-4A15-987C-C583093CB3C0Q40932064-DD79385B-DC1F-47E6-B63E-08393EB2DDB2Q41544565-2435A1DE-B48A-4D2B-ACBC-E705F8EC2358Q45382246-65A7E4F6-3AF2-4D70-B92A-4D58834B232BQ47558114-C0869987-5648-4AB8-B0EE-BA0778C1DFEE
P2860
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@en
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@nl
type
label
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@en
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@nl
prefLabel
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@en
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@nl
P2093
P2860
P1433
P1476
PDL-1 upregulation on monocyte ...... by CCR5-expressing leukocytes.
@en
P2093
Alan L Landay
Andrew W Hardy
Gene M Shearer
Jeffrey L Martinson
Matthew J Dolan
Stephanie A Anderson
P2860
P304
P356
10.1016/J.CLIM.2008.05.009
P577
2008-07-22T00:00:00Z